Orifarm Healthcare - Company finances
|
EUR
|
2022
From: 2022-02-04
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|
|
Financial data
|
||||
| Sales revenue | 100,644 | 371,000 | 398,730 | 458,770 |
| Profit before tax | 4,983 | 19,623 | 22,113 | 47,717 |
| Net profit | 4,983 | 14,492 | 15,345 | 36,263 |
| Equity | 104,983 | 119,475 | 134,820 | 171,083 |
| Liabilities | 29,664 | 30,858 | 30,159 | 2,665,293 |
| Non-current assets | 0 | 0 | 0 | 0 |
| Current assets | 56,647 | 150,333 | 171,099 | 2,870,353 |
| Total assets | 56,647 | 150,333 | 171,099 | 2,870,353 |
|
Taxes paid
|
||||
| STI taxes | - | 40,262 | 50,223 | 52,656 |
|
Financial indicators
|
||||
| Revenue change y/y | - | +268.6% | +7.5% | +15.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 8.8% | 9.6% | 9.0% | 1.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 4.7% | 12.1% | 11.4% | 21.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.0% | 3.9% | 3.8% | 7.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 5.0% | 5.3% | 5.5% | 10.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.3 | 0.2 | 15.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 50,322 | 185,500 | 199,365 | 196,619 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Orifarm Healthcare - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-23 | 2026-07-26 | 4.41 |
| 2026-06-16 | 2026-06-18 | 5436.08 |
| 2026-04-20 | 2026-04-29 | 2.69 |
| 2023-09-18 | 2023-09-19 | 3107.97 |
| 2022-09-16 | 2022-09-27 | 426.39 |
Orifarm Healthcare - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Orifarm Healthcare, UAB (code 306004752) is a Private Limited Liability Company operating in activities of advertising agencies. In 2025, revenue increased to EUR 458.8K from EUR 398.7K in 2024 and EUR 371.0K in 2023, reflecting steady growth of 15.1% year on year and 23.7% over two years. Net profit improved from EUR 14.5K in 2023 to EUR 15.3K in 2024 and EUR 36.3K in 2025, while the profit margin rose to 7.9% from 3.8% in 2024 and 3.9% in 2023. The balance sheet expanded sharply in 2025: total assets reached EUR 2.87M, equity EUR 171.1K and liabilities EUR 2.67M, compared with EUR 171.1K in assets and EUR 30.2K in liabilities in 2024. The equity ratio stood at 6.0%, debt-to-equity at 15.58, ROE at 21.2% and ROA at 1.3%. Revenue per employee was EUR 229.4K and profit per employee EUR 18.1K, while asset turnover was 0.16x.